Janux Therapeutics JANX
NASDAQ JANX
$16.66 -0.40 (-2.34%)
At close: Oct 23, 2026 · 4:00 PM EDT

Janux Therapeutics (JANX) Cash & Current Investments (2020 - 2026)

Updated

Janux Therapeutics' Cash & Current Investments was $970.91 million in Q2 2026, down 2.5% from $996.01 million a year earlier but up 1.5% from the prior quarter.

Analysis

Janux Therapeutics (JANX) Cash & Current Investments (2020 - 2026) Analysis & Trends

At the end of FY2025, Cash & Current Investments at Janux Therapeutics came in at $966.57 million, down 5.7% from FY2024.

  • Cash & Current Investments shows a five-year compound annual growth rate of 162.1% (FY2020 to FY2025).
  • In earlier years, Cash & Current Investments was $1.03 billion in FY2024 (+198.0%), $344.03 million in FY2023 (+5.2%), $327.02 million in FY2022 (-12.8%) and $374.97 million in FY2021.
  • Quarterly Cash & Current Investments has moved between $303.29 million (Q2 2023) and $1.03 billion (Q4 2024) over five years.
  • Compared with a year earlier, Cash & Current Investments has declined for three straight quarters, with growth averaging 54.0% over the last eight quarters.
  • The best year-over-year quarter for Cash & Current Investments over five years was Q4 2024 (growth of 198.0%); the worst was Q2 2023 (a decline of 14.4%).
  • Per Business Quant data, JANX's Cash & Current Investments in the three quarters before Q2 2026 was $956.39 million (Q1 2026), $966.57 million (Q4 2025) and $988.99 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 Janux Therapeutics 1.02 Bn -2.87 Bn - 970.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 970.91 Mn
Mar 31, 2026 956.39 Mn
Dec 31, 2025 966.57 Mn
Sep 30, 2025 988.99 Mn
Jun 30, 2025 996.01 Mn
Mar 31, 2025 1.01 Bn
Dec 31, 2024 1.03 Bn
Sep 30, 2024 658.03 Mn
Jun 30, 2024 646.29 Mn
Mar 31, 2024 651.76 Mn
Dec 31, 2023 344.03 Mn
Sep 30, 2023 349.71 Mn
Jun 30, 2023 303.29 Mn
Mar 31, 2023 316.88 Mn
Dec 31, 2022 327.02 Mn
Sep 30, 2022 338.76 Mn
Jun 30, 2022 354.30 Mn
Mar 31, 2022 361.20 Mn
Dec 31, 2021 374.97 Mn
Sep 30, 2021 387.51 Mn
API Access

Janux Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=JANX&period=max&api_key=YOUR_API_KEY